169 related articles for article (PubMed ID: 18058782)
1. D-SAP: a new, noncytotoxic, and fully protease resistant cell-penetrating peptide.
Pujals S; Fernández-Carneado J; Ludevid MD; Giralt E
ChemMedChem; 2008 Feb; 3(2):296-301. PubMed ID: 18058782
[TBL] [Abstract][Full Text] [Related]
2. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
3. Proline-rich, amphipathic cell-penetrating peptides.
Pujals S; Giralt E
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):473-84. PubMed ID: 18187229
[TBL] [Abstract][Full Text] [Related]
4. Live-cell analysis of cell penetration ability and toxicity of oligo-arginines.
Tünnemann G; Ter-Avetisyan G; Martin RM; Stöckl M; Herrmann A; Cardoso MC
J Pept Sci; 2008 Apr; 14(4):469-76. PubMed ID: 18069724
[TBL] [Abstract][Full Text] [Related]
5. Enantiomer-specific bioactivities of peptidomimetic analogues of mastoparan and mitoparan: characterization of inverso mastoparan as a highly efficient cell penetrating peptide.
Jones S; Howl J
Bioconjug Chem; 2012 Jan; 23(1):47-56. PubMed ID: 22148546
[TBL] [Abstract][Full Text] [Related]
6. Fatty acyl moieties: improving Pro-rich peptide uptake inside HeLa cells.
Fernández-Carneado J; Kogan MJ; Van Mau N; Pujals S; López-Iglesias C; Heitz F; Giralt E
J Pept Res; 2005 Jun; 65(6):580-90. PubMed ID: 15885117
[TBL] [Abstract][Full Text] [Related]
7. S4(13)-PV cell-penetrating peptide forms nanoparticle-like structures to gain entry into cells.
Padari K; Koppel K; Lorents A; Hällbrink M; Mano M; Pedroso de Lima MC; Pooga M
Bioconjug Chem; 2010 Apr; 21(4):774-83. PubMed ID: 20205419
[TBL] [Abstract][Full Text] [Related]
8. Self-assembly of a peptide rod-coil: a polyproline rod and a cell-penetrating peptide Tat coil.
Yoon YR; Lim YB; Lee E; Lee M
Chem Commun (Camb); 2008 Apr; (16):1892-4. PubMed ID: 18401509
[TBL] [Abstract][Full Text] [Related]
9. Creation of a novel cell penetrating peptide, using a random 18mer peptides library.
Nomura T; Kawamura M; Shibata H; Abe Y; Ohkawa A; Mukai Y; Sugita T; Imai S; Nagano K; Okamoto T; Tsutsumi Y; Kamada H; Nakagawa S; Tsunoda S
Pharmazie; 2007 Aug; 62(8):569-73. PubMed ID: 17867548
[TBL] [Abstract][Full Text] [Related]
10. Cell-penetrating cis-gamma-amino-l-proline-derived peptides.
Farrera-Sinfreu J; Giralt E; Castel S; Albericio F; Royo M
J Am Chem Soc; 2005 Jul; 127(26):9459-68. PubMed ID: 15984873
[TBL] [Abstract][Full Text] [Related]
11. Cellular internalization kinetics of (luciferin-)cell-penetrating peptide conjugates.
Eiríksdóttir E; Mäger I; Lehto T; El Andaloussi S; Langel U
Bioconjug Chem; 2010 Sep; 21(9):1662-72. PubMed ID: 20684543
[TBL] [Abstract][Full Text] [Related]
12. The engineering of membrane-permeable peptides.
Carrigan CN; Imperiali B
Anal Biochem; 2005 Jun; 341(2):290-8. PubMed ID: 15907875
[TBL] [Abstract][Full Text] [Related]
13. In vitro uptake and stability study of pVEC and its all-D analog.
Elmquist A; Langel U
Biol Chem; 2003 Mar; 384(3):387-93. PubMed ID: 12715889
[TBL] [Abstract][Full Text] [Related]
14. Preferential uptake of L- versus D-amino acid cell-penetrating peptides in a cell type-dependent manner.
Verdurmen WP; Bovee-Geurts PH; Wadhwani P; Ulrich AS; Hällbrink M; van Kuppevelt TH; Brock R
Chem Biol; 2011 Aug; 18(8):1000-10. PubMed ID: 21867915
[TBL] [Abstract][Full Text] [Related]
15. Translocation or membrane disintegration? Implication of peptide-membrane interactions in pep-1 activity.
Henriques ST; Castanho MA
J Pept Sci; 2008 Apr; 14(4):482-7. PubMed ID: 18181239
[TBL] [Abstract][Full Text] [Related]
16. Cell-penetrating peptides as delivery vehicles for biology and medicine.
Stewart KM; Horton KL; Kelley SO
Org Biomol Chem; 2008 Jul; 6(13):2242-55. PubMed ID: 18563254
[TBL] [Abstract][Full Text] [Related]
17. Specific labeling with potent radiolabels alters the uptake of cell-penetrating peptides.
Walther C; Ott I; Gust R; Neundorf I
Biopolymers; 2009; 92(5):445-51. PubMed ID: 19399852
[TBL] [Abstract][Full Text] [Related]
18. Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.
Deshayes S; Morris M; Heitz F; Divita G
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):537-47. PubMed ID: 18037526
[TBL] [Abstract][Full Text] [Related]
19. Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD.
Watkins CL; Brennan P; Fegan C; Takayama K; Nakase I; Futaki S; Jones AT
J Control Release; 2009 Dec; 140(3):237-44. PubMed ID: 19409429
[TBL] [Abstract][Full Text] [Related]
20. Cell-surface thiols affect cell entry of disulfide-conjugated peptides.
Aubry S; Burlina F; Dupont E; Delaroche D; Joliot A; Lavielle S; Chassaing G; Sagan S
FASEB J; 2009 Sep; 23(9):2956-67. PubMed ID: 19403512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
